drugset / Trial / NCT01651364

A Pilot Study of Cabergoline for the Treatment of Cocaine Dependence

NCT01651364

RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study is to determine the effects of treatment with cabergoline, compared to treatment with placebo, on cocaine induced craving and subjective effects in cocaine-dependent human volunteers.

Timeline

Start
2011-07
Primary completion
2011-10
Completion
2011-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cabergoline Small molecule 0.25 mg